Dr. Andorsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4715 Arapahoe Ave
Boulder, CO 80303Phone+1 303-385-2000Fax+1 303-444-1839- Is this information wrong?
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- Harvard Medical SchoolClass of 2002
Certifications & Licensure
- CA State Medical License 2005 - Present
- CO State Medical License 2010 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant Start of enrollment: 2011 Apr 20
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- Join now to see all
Publications & Presentations
PubMed
- Anxiety and Depression in Metastatic Cancer: A Critical Review of Negative Impacts on Advance Care Planning and End-of-Life Decision Making With Practical Recommendati...Joanna J Arch, Emma E Bright, Lauren B Finkelstein, Regina M Fink, Jill L Mitchell, David J Andorsky, Jean S Kutner> ;JCO Oncology Practice. 2023 Dec 1
- 2 citationsA randomized controlled trial of a multi-modal palliative care intervention to promote advance care planning and psychological well-being among adults with advanced ca...Joanna J Arch, Jill L Mitchell, Sarah J Schmiege, Michael E Levin, Sarah R Genung, Madeline S Nealis, Regina M Fink, Emma E Bright, David J Andorsky, Jean S Kutner> ;BMC Palliative Care. 2022 Nov 17
- 3 citationsBRUIN MCL-321: phase III study of pirtobrutinib versus investigator choice of BTK inhibitor in BTK inhibitor naive mantle cell lymphoma.Toby A Eyre, Nirav N Shah, Martin Dreyling, Wojciech Jurczak, Yucai Wang, Chan Y Cheah, Yuqin Song, Mitul Gandhi, Christopher Chay, Jeff Sharman, David J Andorsky, Han...> ;Future Oncology. 2022 Nov 1
- Join now to see all
Journal Articles
- An Open‐Label Phase 2 Trial of Entospletinib in Indolent Non‐Hodgkin Lymphoma and Mantle Cell LymphomaJeff P Sharman, David J Andorsky, Christopher A Yasenchak, Kathryn S Kolibaba, British Journal of Haematology
Abstracts/Posters
- Debulking Eliminates Need for Hospitalization Prior to Initiating Frontline Venetoclax Therapy in Previously Untreated CLL Patients: A Phase 3b StudyDavid Andorsky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Treatment Patterns and Outcomes of Patients with Relapsed or Refractory Follicular Lymphoma Treated with Idelalisib in a Community Oncology Setting61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- MAGNIFY: Phase IIIb interim analysis of induction R2 followed by maintenance in relapsed/refractory indolent non-Hodgkin lymphoma.2019 ASCO Annual Meeting - 6/1/2019
- Avadomide (CC-), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- US Oncology Research Announces Schedule of Presentations at the Virtual 2020 American Society of Hematology Annual Meeting and ExpositionDecember 2nd, 2020
- US Oncology Research Announces Schedule of Presentations at the 2019 American Society of Hematology Annual Meeting and ExpositionDecember 5th, 2019
- MAGNIFY Trial Shows Durability of Lenalidomide & RituximabNovember 10th, 2017
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Boulder Community HealthBoulder, Colorado
- St Anthony North Medical PavilionBroomfield, Colorado
- AdventHealth AvistaLouisville, Colorado
- University of Colorado HospitalAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: